Analysis of whole genome sequenced cases and controls shows that the association of variants in TOMM40, BCAM, NECTIN2 and APOC1 with late onset Alzheimer’s disease is driven by linkage disequilibrium with APOE ε2/ε3/ε4 alleles

References

• Adzhubei, I., Jordan, D.M., & Sunyaev, S.R. (2013). Predicting functional effect of human missense mutations using PolyPhen-2. Current Protocols in Human Genetics, 7( Unit7), 20. doi:10.1002/0471142905.hg0720s76
   PubMedGoogle Scholar
• Arboleda-Velasquez, J.F., Lopera, F., O’Hare, M., Delgado-Tirado, S., Marino, C., Chmielewska, N., … Quiroz, Y.T. (2019). Resistance to autosomal dominant Alzheimer’s disease in an APOE3 Christchurch homozygote: A case report. Nature Medicine, 25(11), 1680–1683. doi:10.1038/s41591-019-0611-3
   PubMed Web of Science ®Google Scholar
• Bales, K.R., Liu, F., Wu, S., Lin, S., Koger, D., DeLong, C., … Paul, S.M. (2009). Human APOE isoform-dependent effects on brain β-amyloid levels in PDAPP transgenic mice. Journal of Neuroscience., 29(21), 6771–6779. doi:10.1523/JNEUROSCI.0887-09.2009
   PubMed Web of Science ®Google Scholar
• Beecham, G.W., Bis, J.C., Martin, E.R., Choi, S.-H., DeStefano, A.L., van Duijn, C.M., … Schellenberg, G. (2017). The Alzheimer’s disease sequencing project: Study design and sample selection. Neurology. Genetics, 3(5), e194. doi:10.1212/NXG.0000000000000194
   PubMed Web of Science ®Google Scholar
• Blue, E.E., Horimoto, A.R.V.R., Mukherjee, S., Wijsman, E.M., & Thornton, T.A. (2019). Local ancestry at APOE modifies Alzheimer’s disease risk in Caribbean Hispanics. Alzheimers Dement, 15(12), 1524–1532. doi:10.1016/j.jalz.2019.07.016
   PubMed Web of Science ®Google Scholar
• Castellano, J.M., Kim, J., Stewart, F.R., Jiang, H., DeMattos, R.B., Patterson, B.W., … Holtzman, D.M. (2011). Human apoE isoforms differentially regulate brain amyloid-β peptide clearance. Science Translational Medicine, 3(89), 89ra57–ra89ra57. doi:10.1126/scitranslmed.3002156
   PubMed Web of Science ®Google Scholar
• Chang, C.C., Chow, C.C., Tellier, L.C., Vattikuti, S., Purcell, S.M., & Lee, J.J. (2015). Second-generation PLINK: Rising to the challenge of larger and richer datasets. GigaScience, 4, 7. doi:10.1186/s13742-015-0047-8
   PubMed Web of Science ®Google Scholar
• Chiba-Falek, O., Gottschalk, W.K., & Lutz, M.W. (2018). The effects of the TOMM40 poly-T alleles on Alzheimer’s disease phenotypes. Alzheimer’s Dement. 14(5):692–698. doi:10.1016/j.jalz.2018.01.015
   PubMed Web of Science ®Google Scholar
• Corder, E.H., Saunders, A.M., Risch, N.J., Strittmatter, W.J., Schmechel, D.E., Gaskell, P.C., … Pericak-Vance, M.A. (1994). Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nature Genetics, 7(2), 180–184. doi:10.1038/ng0694-180
   PubMed Web of Science ®Google Scholar
• Curtis, D. (2012). A rapid method for combined analysis of common and rare variants at the level of a region, gene, or pathway. Adv Appl Bioinform Chem, 5, 1–9. doi:10.2147/AABC.S33049
   PubMedGoogle Scholar
• Curtis, D. (2016). Pathway analysis of whole exome sequence data provides further support for the involvement of histone modification in the aetiology of schizophrenia. Psychiatric Genetics, 26(5), 223–227. doi:10.1097/YPG.0000000000000132
   PubMed Web of Science ®Google Scholar
• Curtis, D., Bakaya, K., Sharma, L., & Bandyopadhyay, S. (2020). Weighted burden analysis of exome-sequenced late-onset Alzheimer’s cases and controls provides further evidence for a role for PSEN1 and suggests involvement of the PI3K/Akt/GSK-3β and WNT signalling pathways. Annals of Human Genetics, 84(3), 291–302. doi:10.1111/ahg.12375
   PubMed Web of Science ®Google Scholar
• Curtis, D., Coelewij, L., Liu, S.-H., Humphrey, J., & Mott, R. (2018). Weighted burden analysis of exome-sequenced case-control sample implicates synaptic genes in schizophrenia aetiology. Behavior Genetics, 43, 198–208. doi:10.1007/s10519-018-9893-3
   Web of Science ®Google Scholar
• Farrer, L.A., Cupples, L.A., Haines, J.L., Hyman, B., Kukull, W.A., Mayeux, R., … Van Duijn, C.M. (1997). Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: A meta-analysis. Journal of the American Medical Association, 278(16):1349–1356. doi:10.1001/jama.1997.03550160069041
   PubMed Web of Science ®Google Scholar
• Fullerton, S.M., Clark, A.G., Weiss, K.M., Nickerson, D.A., Taylor, S.L., Stengård, J.H., … Sing, C.F. (2000). Apolipoprotein E variation at the sequence haplotype level: Implications for the origin and maintenance of a major human polymorphism. American Journal of Human Genetics, 67(4), 881–900. doi:10.1086/303070
   PubMed Web of Science ®Google Scholar
• Hurko, O., Black, S.E., Doody, R., Doraiswamy, P.M., Gamst, A., Kaye, J., … Green, R.C. (2012). The ADNI Publication Policy: Commensurate recognition of critical contributors who are not authors. NeuroImage, 59(4), 4196–4200. doi:10.1016/j.neuroimage.2011.10.085
   PubMed Web of Science ®Google Scholar
• Kulminski, A.M., Shu, L., Loika, Y., Nazarian, A., Arbeev, K., Ukraintseva, S., … Culminskaya, I. (2019). APOE region molecular signatures of Alzheimer’s disease across races/ethnicities. Neurobiology of Aging, 87, 141.e1. doi:10.1016/j.neurobiolaging.2019.11.007
   PubMed Web of Science ®Google Scholar
• Kumar, P., Henikoff, S., & Ng, P.C. (2009). Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nature Protocols, 4(7), 1073–1081. doi:10.1038/nprot.2009.86
   PubMed Web of Science ®Google Scholar
• Lescai, F., Chiamenti, A.M., Codemo, A., Pirazzini, C., D’Agostino, G., Ruaro, C., … Franceschi, C. (2011). An APOE haplotype associated with decreased ε4 expression increases the risk of late onset Alzheimer’s disease. Journal of Alzheimer’s Disease, 24(2), 235–245. doi:10.3233/JAD-2011-101764
   PubMed Web of Science ®Google Scholar
• McLaren, W., Gil, L., Hunt, S.E., Riat, H.S., Ritchie, G.R.S., Thormann, A., … Cunningham, F. (2016). The ensembl variant effect predictor. Genome Biology, 17(1), 122. doi:10.1186/s13059-016-0974-4
   PubMed Web of Science ®Google Scholar
• Naj, A.C., Lin, H., Vardarajan, B.N., White, S., Lancour, D., Ma, Y., … DeStefano, A.L. (2019). Quality control and integration of genotypes from two calling pipelines for whole genome sequence data in the Alzheimer’s disease sequencing project. Genomics, 111(4), 808–818. doi:10.1016/j.ygeno.2018.05.004
   PubMed Web of Science ®Google Scholar
• Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M.A.R., Bender, D., … Sham, P.C. (2007). PLINK: A tool set for whole-genome association and population-based linkage analyses. American Journal of Human Genetics, 81(3), 559–575. doi:10.1086/519795
   PubMed Web of Science ®Google Scholar
• Purcell, S.M., Wray, N.R., Stone, J.L., Visscher, P.M., O’Donovan, M.C., Sullivan, P.F., … Moran, J.L. (2009). Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature, 460(7256), 748–752. doi:10.1038/nature08185
   PubMed Web of Science ®Google Scholar
• R Core Team. (2014). R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing.
   Google Scholar
• Rajabli, F., Feliciano, B.E., Celis, K., Hamilton-Nelson, K.L., Whitehead, P.L., Adams, L.D., … Pericak-Vance, M.A. (2018). Ancestral origin of ApoE ε4 Alzheimer disease risk in Puerto Rican and African American populations. PLoS Genetics, 14(12), e1007791. doi:10.1371/journal.pgen.1007791
   PubMed Web of Science ®Google Scholar
• Reiman, E.M., Arboleda-Velasquez, J.F., Quiroz, Y.T., Huentelman, M.J., Beach, T.G., Caselli, R.J., … Jun, G.R. (2020). Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study. Nature Communications, 11(1), 667. doi:10.1038/s41467-019-14279-8
   PubMed Web of Science ®Google Scholar
• Strittmatter, W.J., Saunders, A.M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G.S., & Roses, A.D. (1993). Apolipoprotein E: High-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America, 90(5), 1977–1981. doi:10.1073/pnas.90.5.1977
   PubMed Web of Science ®Google Scholar
• Vardarajan, B.N., Barral, S., Jaworski, J., Beecham, G.W., Blue, E., Tosto, G., … Waligorski, J. (2018). Whole genome sequencing of Caribbean Hispanic families with late-onset Alzheimer’s disease. Annals of Clinical and Translational Neurology, 5(4), 406–417. doi:10.1002/acn3.537
   PubMed Web of Science ®Google Scholar
• Wardell, M.R., Brennan, S.O., Janus, E.D., Fraser, R., & Carrell, R.W. (1987). Apolipoprotein E2-Christchurch (136 Arg----Ser). New variant of human apolipoprotein E in a patient with type III hyperlipoproteinemia. The Journal of Clinical Investigation, 80(2), 483–490. doi:10.1172/JCI113096
   PubMed Web of Science ®Google Scholar
• Yamauchi, Y., Deguchi, N., Takagi, C., Tanaka, M., Dhanasekaran, P., Nakano, M., … Saito, H. (2008). Role of the N- and C-terminal domains in binding of apolipoprotein E isoforms to heparan sulfate and dermatan sulfate: A surface plasmon resonance study. Biochemistry, 47(25), 6702–6710. doi:10.1021/bi8003999
   PubMed Web of Science ®Google Scholar
• Zhou, X., Chen, Y., Mok, K.Y., Kwok, T.C.Y., Mok, V.C.T., Guo, Q., … Ip, N.Y. (2019). Non-coding variability at the APOE locus contributes to the Alzheimer’s risk. Nature Communications., 10(1), 3310. doi:10.1038/s41467-019-10945-z
   PubMed Web of Science ®Google Scholar